These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 24152743)
1. Reply to "The significance of significance: overstating in the setting of many comparisons". Luigetti M; Padua L Clin Neurophysiol; 2014 May; 125(5):1073-4. PubMed ID: 24152743 [No Abstract] [Full Text] [Related]
2. The significance of significance: Overstating in the setting of many comparisons. Bromberg MB Clin Neurophysiol; 2014 May; 125(5):1073. PubMed ID: 24239454 [No Abstract] [Full Text] [Related]
3. Clinical-neurophysiological correlations in a series of patients with IgM-related neuropathy. Luigetti M; Padua L; Mazza S; Rossini PM; Sabatelli M; Lo Monaco M Clin Neurophysiol; 2013 Sep; 124(9):1899-903. PubMed ID: 23643315 [TBL] [Abstract][Full Text] [Related]
4. [A case of chronic demyelinating polyneuropathy with benign IgM anti-myelin-associated glycoprotein paraproteinenia--transient improvement with weekly plasmapheresis]. Muramoto T; Yamashita Y; Ohnishi A; Saito T; Kajiyama K; Shirokuchi A Rinsho Shinkeigaku; 1991 Jan; 31(1):38-43. PubMed ID: 1710553 [TBL] [Abstract][Full Text] [Related]
5. Sequential high dose intravenous immunoglobulin for demyelinating neuropathy associated with monoclonal IgM gammapathy. Desson JF; Hachulla E; Facon T; Fournier Y; Hatron PY; Devulder B Eur J Med; 1992 Dec; 1(8):499-50. PubMed ID: 1341212 [No Abstract] [Full Text] [Related]
7. Autoimmunity and demyelinating progressive involvement of nervous system. Dysglobulinemic polyneuropathies as possible pathogenetic model. Logullo F; Di Bella P; Provinciali L Boll Soc Ital Biol Sper; 1988 Aug; 64(8):779-85. PubMed ID: 3214578 [No Abstract] [Full Text] [Related]
8. [A case of IgM paraproteinemia and chronic polyneuropathy with serum antibody reacting with PO protein and myelin-associated glycoprotein]. Nomura K; Hamaguchi K; Hosokawa T; Saito T; Ogawa Y Rinsho Shinkeigaku; 1988 Apr; 28(4):426-32. PubMed ID: 2463888 [No Abstract] [Full Text] [Related]
9. [The diagnosis and therapy of immunologically mediated polyneuropathies]. Jaspert A; Grehl H; Claus D; Engelhardt A; Neundörfer B Dtsch Med Wochenschr; 1993 Aug; 118(33):1205-11. PubMed ID: 8359113 [No Abstract] [Full Text] [Related]
10. Subacute polyneuropathy in a patient undergoing peritoneal dialysis: clinical features and new pathophysiologic insights. Raina R; Bianco C; Fedak K; Garg G; Gebreselassie S; Schreiber MJ; Heyka RC Adv Perit Dial; 2011; 27():125-8. PubMed ID: 22073843 [TBL] [Abstract][Full Text] [Related]
11. [Neuropathy associated with dysglobulinemia and monoclonal gammopathy]. Saito T Nihon Rinsho; 1994 Nov; 52(11):2976-83. PubMed ID: 7996697 [TBL] [Abstract][Full Text] [Related]
12. Subacute demyelinating polyneuropathy in B-cell lymphoma with IgM antibodies against glycolipid GD1b. Marfia GA; Pachatz C; Terracciano C; Leone G; Bernardini S; Bernardi G; Massa R Neurol Sci; 2005 Dec; 26(5):355-7. PubMed ID: 16388373 [TBL] [Abstract][Full Text] [Related]
13. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies. van Nes SI; Vanhoutte EK; van Doorn PA; Hermans M; Bakkers M; Kuitwaard K; Faber CG; Merkies IS Neurology; 2011 Jan; 76(4):337-45. PubMed ID: 21263135 [TBL] [Abstract][Full Text] [Related]
14. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies. Lopate G; Choksi R; Pestronk A Muscle Nerve; 2002 Jun; 25(6):828-36. PubMed ID: 12115971 [TBL] [Abstract][Full Text] [Related]